Octyl 4-methoxycinnamate

CAS No. 5466-77-3

Octyl 4-methoxycinnamate ( —— )

Catalog No. M14965 CAS No. 5466-77-3

Octinoxate is an organic compound that is an ingredient in some sunscreens and lip balms, primarily used is in sunscreens and other cosmetics to absorb UV-B rays from the sun.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 37 In Stock
1G 43 In Stock

Biological Information

  • Product Name
    Octyl 4-methoxycinnamate
  • Note
    Research use only, not for human use.
  • Brief Description
    Octinoxate is an organic compound that is an ingredient in some sunscreens and lip balms, primarily used is in sunscreens and other cosmetics to absorb UV-B rays from the sun.
  • Description
    Octinoxate is an organic compound that is an ingredient in some sunscreens and lip balms, primarily used is in sunscreens and other cosmetics to absorb UV-B rays from the sun, protecting the skin from damage. It is also used to reduce the appearance of scars.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    5466-77-3
  • Formula Weight
    290.40
  • Molecular Formula
    C18H26O3
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: > 10 mM
  • SMILES
    CCCCC(CC)COC(=O)/C=C/C1=CC=C(C=C1)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hayden CG, et al. Skin Pharmacol Physiol. 2005 Jul-Aug;18(4):170-4.
molnova catalog
related products
  • AMAS

    AMAS is a nonclaevable heterobifunctional crosslinker with NHS ester and maleimide groups that allows covalent conjugation of amine- and sulfhydryl-containing molecules.

  • Angelicain

    Angelicain is a constituent of Cimicifuga foetida with anti-inflammatory activity.

  • Trimethoxystilbene

    3, 5, 4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast Y cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.